Lester M. Crawford, DVM, PhD, was confirmed by the Senate as the commissioner
of the US Food and Drug Administration (FDA) on July 18.
Crawford has been the acting commissioner since March 2004, when Mark
B. McClellan, MD, PhD, left the post to become the administrator of the Centers
for Medicare & Medicaid Services. He previously served as the agency’s
Although President Bush nominated Crawford for commissioner in February,
a senate vote to determine his confirmation was delayed after three senators
put a hold on the vote. Sen Patty Murray (D, Wash) and Sen Hillary Rodham
Clinton (D, NY) did so pending an FDA decision on the over-the-counter emergency
contraceptive, Plan B, but released the hold after Department of Health and
Human Services Secretary Mike Leavitt said the agency would make a decision
by September 1. Sen Tom Coburn (R, Wyo) had also put a hold on the nomination
because he contends that the FDA should change the labels on condoms to clarify
their effectiveness; he also removed his hold.
Kuehn BM. Crawford to Lead FDA. JAMA. 2005;294(10):1201. doi:10.1001/jama.294.10.1201-b
Customize your JAMA Network experience by selecting one or more topics from the list below.